home All News open_in_new Full Article
Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab
Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and generalized myasthenia gravis (gMG) in the U.S. Partnership supports Teva’s Pivot to Growth strategy and adds to its broad biosimilar portfolio INCHEON, Korea and TEL AVIV, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) — Samsung […]
today 8 hours ago attach_file Culture
attach_file
Other
attach_file
Politics
attach_file
Society
attach_file
Economics
attach_file
Sport
attach_file
Other
attach_file
Politics
attach_file
Society
attach_file
Economics
attach_file
Culture
attach_file
Other
attach_file
Society
attach_file
Culture
attach_file
Other
attach_file
Culture
attach_file
Other
attach_file
Culture
35 hours ago
Objectway Expands Into the MENA Region by Signing With Kuwait Financial Centre ‘Markaz’
attach_file
Other
ID: 15940960